Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
EIR issued July 23, 2021 · Andover, Massachusetts
- Inspection
- Jul 19 – Jul 23, 2021
- Investigators
- Anissa M. Cheung· Debra M. Emerson· Ekaterina Allen
- Pages
- 86
- FEI number
- 1222181
In short: This is FDA's Establishment Inspection Report (EIR) for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC in Andover, Massachusetts (FEI 1222181), covering the inspection of Jul 19 – Jul 23, 2021. It is the investigator's full narrative of what they examined, who they spoke to and what they found. The investigators were Anissa M. Cheung, Debra M. Emerson, Ekaterina Allen and Kathleen R. Jones.
Inside this inspection report
The investigator's narrative
The full inspection report: what the investigator looked at, who they spoke to and what they found, in their own words.
Get the full EIRThis inspection in context
Anissa M. Cheung
7 documents · 2017–2024
Cites 211.192 (production record review) more than any other section. Most of their documents are for sites in Massachusetts.
The firmWyeth BioPharma Division of Wyeth Pharmaceuticals LLC history
All 9 documents on file for this site, in date order, with what was cited at each inspection.
Similar documentsMore eirs
Browse other documents of this type.
Questions about this EIR
Who inspected Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC?
Anissa M. Cheung, Debra M. Emerson, Ekaterina Allen and Kathleen R. Jones are named on this EIR, for the inspection of Jul 19 – Jul 23, 2021. Each investigator has a profile showing what they cite most.
When was Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC inspected by FDA?
The inspection ran Jul 19 – Jul 23, 2021.
How do I get the full EIR for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC?
Download the original PDF from FDA Intel for $550, with no subscription. You also get an invoice PDF with the order.